FRI0313 the Efficacy and Safety of Tocilizumab Therapy in Patients With Polymyalgia Rheumatica Who Were Resistant or Intolerant to Glucocorticoids and Additional Methotrexate

doi 10.1136/annrheumdis-2017-eular.5945
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ Publishing Group Ltd and European League Against Rheumatism

Related search

Tocilizumab Ameliorates Clinical Symptoms in Polymyalgia Rheumatica

Journal of Rheumatology
RheumatologyAllergyImmunology
2010English

Long-Term Efficacy and Safety of Dasatinib in Patients With Chronic Myeloid Leukemia in Accelerated Phase Who Are Resistant to or Intolerant of Imatinib

Blood Cancer Journal
OncologyHematology
2018English

PMS48 Tocilizumab in Methotrexate-Intolerant or Contraindicated Patients – A Cost-Utility Model for the UK

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Long-Term Safety and Efficacy of Dasatinib in the Treatment of Chronic-Phase Chronic Myeloid Leukemia Patients Resistant or Intolerant to Imatinib

Blood and Lymphatic Cancer: Targets and Therapy
2014English

A Phase 2 Study to Assess the Safety and Efficacy of Umbralisib in Patients With Chronic Lymphocytic Leukemia (Cll) Who Are Intolerant to Prior BTK or Pi3k Delta Inhibitor Therapy

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Cancerogenesis and Polymyalgia Rheumatica

Journal of Carcinogenesis & Mutagenesisc
2016English

Giant-Cell Arteritis and Polymyalgia Rheumatica

Annals of Internal Medicine
Internal MedicineMedicine
2003English

Diagnosis and Management of Polymyalgia Rheumatica

British Journal of General Practice
MedicineFamily Practice
2012English

Efficacy and Safety of Methotrexate Add-On Therapy Versus Placebo for Patients With Chronic Spontaneous Urticaria Resistant to H1-Antihistamines: A Randomized, Controlled Trial

Journal of the American Academy of Dermatology
Dermatology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy